English
Aarti Drugs Q3 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
399.40
2.65 (0.67%)
2.65 (0.67%)Volume5.51 K
Updated: Tue 9 Dec, 2025 | 15:29:33
NSE
397.950.20 (0.05%)
0.20 (0.05%)Volume3.05 L
Updated: Tue 9 Dec, 2025 | 15:31:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 508.67 | 545.01 | -6.67% |
| Depreciation/ Amortization | 13.80 | 13.72 | 0.58% |
| Operating Income | 47.93 | 53.32 | -10.11% |
| Net Income | 37.04 | 35.01 | 5.82% |
| Other Operating Expenses Total | 115.72 | 110.73 | 4.51% |
| Net Income Before Taxes | 50.76 | 45.88 | 10.64% |
| Total Revenue | 556.60 | 598.33 | -6.97% |
| Selling/ General/ Admin Expenses Total | 27.76 | 26.56 | 4.52% |
| Diluted Normalized EPS | 4.06 | 3.83 | 6.01% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.